Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ruxolitinib formulation for reduction of itch in atopic dermatitis

Ruxolitinib formulation for reduction of itch in atopic dermatitis

US Patent 12396993 · Granted Aug 26, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers for vitiligo2025
Biomarkers for graft-versus-host disease2025
Treatment of hidradenitis suppurativa using JAK inhibitors2025
Topical treatment of vitiligo by a JAK inhibitor2025
Topical treatment of vitiligo by a JAK inhibitor2025
Topical treatment of vitiligo by a JAK inhibitor2025
Biomarkers for graft-versus-host disease2025
Biomarkers for graft-versus-host disease2024
System and method for generating diagnostic health information using deep learni2024
Macro-based diagnoses for anatomic pathology2024
Macro-based diagnoses for anatomic pathology2024
JAK1 pathway inhibitors for the treatment of vitiligo2024